Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Tangible Book Value Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Work In Process

Daily Values

Growth Metrics

Others

China Pharma Holdings (CPHI) Short-term Investments (2019)

Historic Short-term Investments for China Pharma Holdings (CPHI) over the last 1 years, with Q4 2019 value amounting to $109908.0.

China Pharma Holdings' Short-term Investments changed N/A to $109908.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $109908.0, marking a year-over-year change of. This contributed to the annual value of $109908.0 for FY2019, which is N/A changed from last year.
Latest data reveals that China Pharma Holdings reported Short-term Investments of $109908.0 as of Q4 2019.
Over the past 5 years, China Pharma Holdings' Short-term Investments peaked at $109908.0 during Q4 2019, and registered a low of $109908.0 during Q4 2019.